Blueprint Medicines Corp Quarterly Share-based Payment Arrangement, Expense in USD from Q1 2014 to Q3 2024

Taxonomy & unit
us-gaap: USD
Description
Amount of expense for award under share-based payment arrangement. Excludes amount capitalized.
Summary
Blueprint Medicines Corp quarterly/annual Share-based Payment Arrangement, Expense history and growth rate from Q1 2014 to Q3 2024.
  • Blueprint Medicines Corp Share-based Payment Arrangement, Expense for the quarter ending September 30, 2024 was $28.3M, a 22.6% increase year-over-year.
  • Blueprint Medicines Corp Share-based Payment Arrangement, Expense for the twelve months ending September 30, 2024 was $103M, a 7.18% increase year-over-year.
  • Blueprint Medicines Corp annual Share-based Payment Arrangement, Expense for 2023 was $92.7M, a 6.36% decline from 2022.
  • Blueprint Medicines Corp annual Share-based Payment Arrangement, Expense for 2022 was $99M, a 8.01% increase from 2021.
  • Blueprint Medicines Corp annual Share-based Payment Arrangement, Expense for 2021 was $91.6M, a 21.3% increase from 2020.
Share-based Payment Arrangement, Expense, Trailing 12 Months (USD)
Share-based Payment Arrangement, Expense, Quarterly (USD)
Share-based Payment Arrangement, Expense, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q3 2024 $103M $28.3M +$5.21M +22.6% Jul 1, 2024 Sep 30, 2024 10-Q 2024-10-30
Q2 2024 $97.9M $28M +$4.2M +17.6% Apr 1, 2024 Jun 30, 2024 10-Q 2024-08-01
Q1 2024 $93.7M $24.2M +$1.03M +4.44% Jan 1, 2024 Mar 31, 2024 10-Q 2024-05-02
Q4 2023 $92.7M $22.6M -$3.53M -13.5% Oct 1, 2023 Dec 31, 2023 10-K 2024-02-15
Q3 2023 $96.2M $23.1M -$1.04M -4.31% Jul 1, 2023 Sep 30, 2023 10-Q 2024-10-30
Q2 2023 $97.2M $23.8M -$1.53M -6.02% Apr 1, 2023 Jun 30, 2023 10-Q 2024-08-01
Q1 2023 $98.8M $23.2M -$203K -0.87% Jan 1, 2023 Mar 31, 2023 10-Q 2024-05-02
Q4 2022 $99M $26.1M +$3.44M +15.1% Oct 1, 2022 Dec 31, 2022 10-K 2024-02-15
Q3 2022 $95.5M $24.1M +$151K +0.63% Jul 1, 2022 Sep 30, 2022 10-Q 2023-10-26
Q2 2022 $95.4M $25.3M +$1.04M +4.28% Apr 1, 2022 Jun 30, 2022 10-Q 2023-08-02
Q1 2022 $94.3M $23.4M +$2.72M +13.1% Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-04
Q4 2021 $91.6M $22.7M +$3.18M +16.3% Oct 1, 2021 Dec 31, 2021 10-K 2024-02-15
Q3 2021 $88.5M $24M +$4.32M +22% Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-01
Q2 2021 $84.1M $24.3M +$4.78M +24.5% Apr 1, 2021 Jun 30, 2021 10-Q 2022-08-02
Q1 2021 $79.4M $20.7M +$3.83M +22.7% Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-03
Q4 2020 $75.5M $19.5M +$3.81M +24.2% Oct 1, 2020 Dec 31, 2020 10-K 2023-02-16
Q3 2020 $71.7M $19.6M +$4.64M +31% Jul 1, 2020 Sep 30, 2020 10-Q 2021-10-28
Q2 2020 $67.1M $19.5M +$5.86M +42.9% Apr 1, 2020 Jun 30, 2020 10-Q 2021-07-29
Q1 2020 $61.2M $16.9M +$6.56M +63.8% Jan 1, 2020 Mar 31, 2020 10-Q 2021-04-29
Q4 2019 $54.7M $15.7M +$6.87M +77.7% Oct 1, 2019 Dec 31, 2019 10-K 2022-02-17
Q3 2019 $47.8M $15M +$6.6M +78.7% Jul 1, 2019 Sep 30, 2019 10-Q 2020-10-29
Q2 2019 $41.2M $13.7M +$5.91M +76.1% Apr 1, 2019 Jun 30, 2019 10-Q 2020-07-31
Q1 2019 $35.3M $10.3M +$4.75M +85.5% Jan 1, 2019 Mar 31, 2019 10-Q 2020-05-06
Q4 2018 $30.5M $8.83M +$5.13M +138% Oct 1, 2018 Dec 31, 2018 10-K 2021-02-17
Q3 2018 $25.4M $8.39M +$4.79M +133% Jul 1, 2018 Sep 30, 2018 10-Q 2019-11-05
Q2 2018 $20.6M $7.76M +$4.78M +161% Apr 1, 2018 Jun 30, 2018 10-Q 2019-08-01
Q1 2018 $15.8M $5.55M +$3.31M +148% Jan 1, 2018 Mar 31, 2018 10-Q 2019-05-09
Q4 2017 $12.5M $3.71M +$2.06M +125% Oct 1, 2017 Dec 31, 2017 10-K 2020-02-13
Q3 2017 $10.5M $3.6M +$1.69M +88.9% Jul 1, 2017 Sep 30, 2017 10-Q 2018-10-30
Q2 2017 $8.77M $2.98M +$1.49M +100% Apr 1, 2017 Jun 30, 2017 10-Q 2018-08-01
Q1 2017 $7.28M $2.24M +$1.14M +103% Jan 1, 2017 Mar 31, 2017 10-Q 2017-05-03
Q4 2016 $6.14M $1.65M +$451K +37.7% Oct 1, 2016 Dec 31, 2016 10-K 2019-02-26
Q3 2016 $5.69M $1.91M +$934K +96.2% Jul 1, 2016 Sep 30, 2016 10-Q 2017-10-31
Q2 2016 $4.76M $1.49M -$687K -31.6% Apr 1, 2016 Jun 30, 2016 10-Q 2017-08-02
Q1 2016 $5.44M $1.1M +$262K +31.2% Jan 1, 2016 Mar 31, 2016 10-Q 2017-05-03
Q4 2015 $5.18M $1.2M -$105K -8.08% Oct 1, 2015 Dec 31, 2015 10-K 2018-02-21
Q3 2015 $5.29M $971K +$404K +71.3% Jul 1, 2015 Sep 30, 2015 10-Q 2016-11-10
Q2 2015 $4.88M $2.17M +$1.98M +1032% Apr 1, 2015 Jun 30, 2015 10-Q 2016-08-09
Q1 2015 $2.9M $840K +$573K +215% Jan 1, 2015 Mar 31, 2015 10-Q 2016-05-10
Q4 2014 $2.33M $1.3M Oct 1, 2014 Dec 31, 2014 10-K 2017-03-09
Q3 2014 $567K Jul 1, 2014 Sep 30, 2014 10-Q 2015-11-09
Q2 2014 $192K Apr 1, 2014 Jun 30, 2014 10-Q 2015-08-10
Q1 2014 $267K Jan 1, 2014 Mar 31, 2014 10-Q 2015-06-11
* An asterisk sign (*) next to the value indicates that the value is likely invalid.